Daily BriefsHealthcare

Daily Brief Health Care: Sichuan Biokin Pharmaceutical, TSE Tokyo Price Index TOPIX, Classys and more

In today’s briefing:

  • STAR50 Index Rebalance: Big Impact Expected; Inclusion Up 40% in One Month
  • Investors Will Again Demand Concrete Measures to Raise ROE and Boost Shareholder Returns in FY3/2025
  • Classys (214150 KS): Record High Quarterly Performance in Q3; 2024 to Continue to Be Radiant


STAR50 Index Rebalance: Big Impact Expected; Inclusion Up 40% in One Month

By Brian Freitas


Investors Will Again Demand Concrete Measures to Raise ROE and Boost Shareholder Returns in FY3/2025

By Aki Matsumoto

  • The carryback of pension obligations and expenses resulting from higher bond yields is a factor in the increase in operating profit.
  • While this’ll lead to higher EPS, which should lead to higher dividends and more room for stock price appreciation, there’s concern that inflating the B/S will lead to stagnant ROE.
  • In addition, since FY3/2024 profits will be boosted by pension financing factors unrelated to the core business, lower profit growth rate in FY3/2025 will put pressure on the stock price.

Classys (214150 KS): Record High Quarterly Performance in Q3; 2024 to Continue to Be Radiant

By Tina Banerjee

  • Classys (214150 KS) reported solid performance in 3Q23, with revenue and operating profit growing 45% and 41%, YoY, respectively, mainly driven by export in devices and domestic sales of consumables.  
  • Despite being an offseason, Q3 2023 witnessed increase in both the number of countries selling the new product Ultraformer MPT and the monthly average domestic sales of Volnewmer.
  • Continued improvement in equipment sale and increasing consumables contribution should drive growth in 2024. Entry into the U.S. and China will be the key for re-rating of the stock.   

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars